Skip to main content

Changes in histological diagnosis in soft tissue tumours from biopsy to final surgery specimen: causes and consequences

Maurer-Ertl W, Leithner A, Tauber S, Frohlich EV, Kuerzl G, Glehr M, Zacherl M, Liegl B, Windhager R

Publication: European Surgical Research (2009) • Vol 41 • Page 150

Purpose

The purpose of this paper was to identify cases from referring institutions and from the tumor center at the Medical University of Graz in Austria where initial soft tissue tumor diagnoses were revised due to biopsy sampling error.

Conclusion

Proper imaging prior to and during biopsy is required to reduce misdiagnosis. Pathologists with sufficient experience specializing in soft tissue sarcoma are required to reduce misdiagnosis. Tumor heterogeneity associated with tumor type is an unavoidable (although low) contributing source in misdiagnosis.

Studies (1)

Purpose

The purpose of this study was to identify cases where initial soft tissue tumor diagnoses were revised due to biopsy sampling error.

Summary of Findings

Retrospective examination of 663 patients initially diagnosed with cancer of soft tissue at multiple institutions over a 10 y period revealed 113 cases in which the initial diagnosis differed from the final histology-based diagnosis. Of the 113 cases, 20% required correction due to an initial misdiagnosis, although reasons for an altered diagnosis among other cases were not identified by the authors. When the data was grouped by institution, the prevalence of misdiagnosis was lower when both the initial and final diagnoses were conducted at a specialized tumor center (5.5%) compared to cases in which the initial diagnosis was conducted at a referring institution (20%). The authors attribute institution-specific differences in misdiagnosis rate to inadequate experience with soft tissue tumors by the resident pathologist, and the use of appropriate imaging before and during biopsy procurement. Importantly, the authors note that sampling errors associated with tumor type and heterogeneity resulted in an unavoidable, albeit low (4%), incidence of misdiagnosis.

  • Biospecimens

    TissueMuscle (Skeletal)
    TissueBone
    TissueLymph Node
    TissueAdipose
    TissueOther
  • Preservation Types

    Formalin
  • Diagnoses

    NeoplasticBenign
    NeoplasticSarcoma
    NeoplasticLymphoma
    NeoplasticCarcinoma
  • Platforms

    MorphologyX-ray
    MorphologyH-and-E microscopy
  • Pre-analytical Factors

    ClassificationPre-Analytical FactorValue(s)
    Biospecimen AcquisitionBiospecimen location
    Bone
    Fat cells
    Lymph node
    Muscle
    Unspecified locations
    Biospecimen AcquisitionMethod of tissue acquisition
    CT-guided biopsy
    Core needle biopsy
    Excisional biopsy
    Incisional biopsy
    Biospecimen Aliquots and ComponentsBiospecimen heterogeneity
    Atypical tumor mass
    Well-differentiated tumor mass